Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 40

1.

Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI.

Landau SM, Horng A, Fero A, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2016 Mar 11. pii: 10.1212/WNL.0000000000002576. [Epub ahead of print]

PMID:
26968515
2.

Comparison of Visual and Quantitative Florbetapir F 18 Positron Emission Tomography Analysis in Predicting Mild Cognitive Impairment Outcomes.

Schreiber S, Landau SM, Fero A, Schreiber F, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.

JAMA Neurol. 2015 Oct;72(10):1183-90. doi: 10.1001/jamaneurol.2015.1633.

PMID:
26280102
3.

Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures.

Apostolova LG, Hwang KS, Avila D, Elashoff D, Kohannim O, Teng E, Sokolow S, Jack CR, Jagust WJ, Shaw L, Trojanowski JQ, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2015 Feb 17;84(7):729-37. doi: 10.1212/WNL.0000000000001231. Epub 2015 Jan 21.

4.

Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression.

Caroli A, Prestia A, Galluzzi S, Ferrari C, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen C, Wall AE, Carter SF, Schöll M, Choo IH, Grimmer T, Redolfi A, Nordberg A, Scheltens P, Drzezga A, Frisoni GB; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2015 Feb 3;84(5):508-15. doi: 10.1212/WNL.0000000000001209. Epub 2015 Jan 7.

5.

Intravascular frequency-domain optical coherence tomography assessment of carotid artery disease in symptomatic and asymptomatic patients.

Jones MR, Attizzani GF, Given CA 2nd, Brooks WH, Ganocy SJ, Ramsey CN, Fujino Y, Bezerra HG, Costa MA.

JACC Cardiovasc Interv. 2014 Jun;7(6):674-84. doi: 10.1016/j.jcin.2014.01.163.

6.

Optical coherence tomography of the intracranial vasculature and Wingspan stent in a patient.

Given CA 2nd, Ramsey CN 3rd, Attizzani GF, Jones MR, Brooks WH, Bezerra HG, Costa MA.

J Neurointerv Surg. 2015 Jun;7(6):e22. doi: 10.1136/neurintsurg-2014-011114.rep. Epub 2014 May 20.

PMID:
24847090
7.

Optical coherence tomography of the intracranial vasculature and Wingspan stent in a patient.

Given CA 2nd, Ramsey CN 3rd, Attizzani GF, Jones MR, Brooks WH, Bezerra HG, Costa MA.

BMJ Case Rep. 2014 May 16;2014. pii: bcr2014011114. doi: 10.1136/bcr-2014-011114.

PMID:
24835808
8.

Frequency-domain optical coherence tomography assessment of human carotid atherosclerosis using saline flush for blood clearance without balloon occlusion.

Given CA 2nd, Attizzani GF, Jones MR, Ramsey CN 3rd, Brooks WH, Costa MA, Bezerra HG.

AJNR Am J Neuroradiol. 2013 Jul;34(7):1414-8. doi: 10.3174/ajnr.A3411. Epub 2013 Feb 7.

9.

Frequency-domain optical coherence tomography assessment of very late vascular response after carotid stent implantation.

Attizzani GF, Jones MR, Given CA 2nd, Brooks WH, Bezerra HG, Costa MA.

J Vasc Surg. 2013 Jul;58(1):201-4. doi: 10.1016/j.jvs.2012.11.038. Epub 2013 Jan 26.

10.

Predicting missing biomarker data in a longitudinal study of Alzheimer disease.

Lo RY, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2012 May 1;78(18):1376-82. doi: 10.1212/WNL.0b013e318253d5b3. Epub 2012 Apr 4.

11.

Intravascular frequency-domain optical coherence tomography assessment of atherosclerosis and stent-vessel interactions in human carotid arteries.

Jones MR, Attizzani GF, Given CA 2nd, Brooks WH, Costa MA, Bezerra HG.

AJNR Am J Neuroradiol. 2012 Sep;33(8):1494-501. doi: 10.3174/ajnr.A3016. Epub 2012 Mar 15.

12.

Predicting MCI outcome with clinically available MRI and CSF biomarkers.

Heister D, Brewer JB, Magda S, Blennow K, McEvoy LK; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2011 Oct 25;77(17):1619-28. doi: 10.1212/WNL.0b013e3182343314. Epub 2011 Oct 12.

13.

Longitudinal change of biomarkers in cognitive decline.

Lo RY, Hubbard AE, Shaw LM, Trojanowski JQ, Petersen RC, Aisen PS, Weiner MW, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.

Arch Neurol. 2011 Oct;68(10):1257-66. doi: 10.1001/archneurol.2011.123. Epub 2011 Jun 13.

PMID:
21670386
14.

Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort.

Kim S, Swaminathan S, Shen L, Risacher SL, Nho K, Foroud T, Shaw LM, Trojanowski JQ, Potkin SG, Huentelman MJ, Craig DW, DeChairo BM, Aisen PS, Petersen RC, Weiner MW, Saykin AJ; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2011 Jan 4;76(1):69-79. doi: 10.1212/WNL.0b013e318204a397. Epub 2010 Dec 1.

15.

Discovering genetic associations with high-dimensional neuroimaging phenotypes: A sparse reduced-rank regression approach.

Vounou M, Nichols TE, Montana G; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2010 Nov 15;53(3):1147-59. doi: 10.1016/j.neuroimage.2010.07.002. Epub 2010 Jul 17.

PMID:
20624472
16.

Reduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustment.

Schott JM, Bartlett JW, Barnes J, Leung KK, Ourselin S, Fox NC; Alzheimer's Disease Neuroimaging Initiative investigators.

Neurobiol Aging. 2010 Aug;31(8):1452-62, 1462.e1-2. doi: 10.1016/j.neurobiolaging.2010.04.011.

17.

Effects of BDNF Val66Met polymorphism on brain metabolism in Alzheimer's disease.

Xu C, Wang Z, Fan M, Liu B, Song M, Zhen X, Jiang T; Alzheimer's Disease Neuroimaging Initiative.

Neuroreport. 2010 Aug 23;21(12):802-7. doi: 10.1097/WNR.0b013e32833ccaf4.

18.

Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease.

Wolk DA, Dickerson BC; Alzheimer's Disease Neuroimaging Initiative.

Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10256-61. doi: 10.1073/pnas.1001412107. Epub 2010 May 17.

19.

A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly.

Ho AJ, Stein JL, Hua X, Lee S, Hibar DP, Leow AD, Dinov ID, Toga AW, Saykin AJ, Shen L, Foroud T, Pankratz N, Huentelman MJ, Craig DW, Gerber JD, Allen AN, Corneveaux JJ, Stephan DA, DeCarli CS, DeChairo BM, Potkin SG, Jack CR Jr, Weiner MW, Raji CA, Lopez OL, Becker JT, Carmichael OT, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Proc Natl Acad Sci U S A. 2010 May 4;107(18):8404-9. doi: 10.1073/pnas.0910878107. Epub 2010 Apr 19.

20.

Voxelwise genome-wide association study (vGWAS).

Stein JL, Hua X, Lee S, Ho AJ, Leow AD, Toga AW, Saykin AJ, Shen L, Foroud T, Pankratz N, Huentelman MJ, Craig DW, Gerber JD, Allen AN, Corneveaux JJ, Dechairo BM, Potkin SG, Weiner MW, Thompson P; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2010 Nov 15;53(3):1160-74. doi: 10.1016/j.neuroimage.2010.02.032. Epub 2010 Feb 17.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk